RESUMO
Researchers around the globe have been mounting, accelerating, and redeploying efforts across disciplines and organizations to tackle the SARS-CoV-2 outbreak. However, humankind continues to be afflicted by numerous other devastating diseases in increasing numbers. Here, we outline considerations and opportunities toward striking a good balance between maintaining and redefining research priorities.
Assuntos
Pesquisa Biomédica , Infecções por Coronavirus , Pandemias , Pneumonia Viral , Pesquisa Biomédica/economia , COVID-19 , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/prevenção & controle , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/tratamento farmacológico , Infecções por Coronavirus/prevenção & controle , Ciência de Dados/instrumentação , Ciência de Dados/métodos , Atenção à Saúde , Humanos , Invenções , Doenças Metabólicas/diagnóstico , Doenças Metabólicas/tratamento farmacológico , Doenças Metabólicas/prevenção & controle , Neoplasias/diagnóstico , Neoplasias/tratamento farmacológico , Neoplasias/prevenção & controle , Pandemias/prevenção & controle , Pneumonia Viral/diagnóstico , Pneumonia Viral/tratamento farmacológico , Pneumonia Viral/prevenção & controle , PesquisaRESUMO
OBJECTIVE: The study presents an overview of the research activity in Big Data Analytics (BDA) in the field of health and demonstrates the existing knowledge through related examples. The objective is to inform health librarians about the nature and magnitude of the technological innovations in health information analysis tools, its influence, and where and how further material could be searched. METHODS: We performed a bibliometric and co-citation analysis within a total of 804 papers published between 2000 and 2016 and retrieved from the Web of Science and Scopus databases. Using the NVivo text analysis software, we identified the stakeholders of BDA in health and innovative decision support systems in the field. RESULTS: Our findings show a tremendous increase in published papers after 2014. Most of them are relevant to neurology and medical oncology. The stakeholders are clinicians, researchers, patients, administrators, IT specialists, vendors and policymakers. New BDA tools in medicine are mostly developed for disease monitoring purposes while they utilise visualisation to identify disease patterns and statistical analysis of past data for making predictions. CONCLUSIONS: Health analytics provide a unique opportunity for advancing health information research and medical decision making. It provides health information professionals with new tools in problem-solving offering new perspectives in prognosis and diagnosis of diseases.